These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 26008841)
1. Highlights from the 25th ECCMID. Bosurgi R; McConnell J; Mushtaq A Lancet Infect Dis; 2015 Jun; 15(6):639-40. PubMed ID: 26008841 [No Abstract] [Full Text] [Related]
2. How should nursing homes use vaccine to prevent zoster? Drinka PJ J Am Med Dir Assoc; 2007 Sep; 8(7):419-20. PubMed ID: 17845943 [No Abstract] [Full Text] [Related]
3. Herpes zoster vaccination among adults aged 60 years and older, in the U.S., 2008. Lu PJ; Euler GL; Harpaz R Am J Prev Med; 2011 Feb; 40(2):e1-6. PubMed ID: 21238856 [TBL] [Abstract][Full Text] [Related]
4. Herpes zoster vaccination in people aged 50-59 years. Li HT; Lu S; Liu JM Clin Infect Dis; 2012 Apr; 54(7):929-30. PubMed ID: 22291102 [No Abstract] [Full Text] [Related]
5. Varicella-zoster vaccine for the prevention of herpes zoster. Kimberlin DW; Whitley RJ N Engl J Med; 2007 Mar; 356(13):1338-43. PubMed ID: 17392303 [No Abstract] [Full Text] [Related]
6. A new vaccine to prevent herpes zoster. Cohen JI N Engl J Med; 2015 May; 372(22):2149-50. PubMed ID: 25916342 [No Abstract] [Full Text] [Related]
7. Herpes zoster vaccine: clinical trial evidence and implications for medical practice. Burke MS J Am Osteopath Assoc; 2007 Mar; 107(3 Suppl 1):S14-8. PubMed ID: 17488883 [TBL] [Abstract][Full Text] [Related]
11. Vaccination: a new option to reduce the burden of herpes zoster. Mick G Expert Rev Vaccines; 2010 Mar; 9(3 Suppl):31-5. PubMed ID: 20192716 [TBL] [Abstract][Full Text] [Related]
12. Varicella-zoster vaccine. Senanayake SN N Engl J Med; 2007 Jul; 357(1):89-90. PubMed ID: 17615639 [No Abstract] [Full Text] [Related]
15. Herpes zoster vaccine: a shot to maintain wellbeing. Michel JP Aging Clin Exp Res; 2015 Feb; 27(1):1-3. PubMed ID: 25585545 [No Abstract] [Full Text] [Related]
16. Immunogenicity and safety of an adjuvanted herpes zoster subunit candidate vaccine in adults ≥ 50 years of age with a prior history of herpes zoster: A phase III, non-randomized, open-label clinical trial. Godeaux O; Kovac M; Shu D; Grupping K; Campora L; Douha M; Heineman TC; Lal H Hum Vaccin Immunother; 2017 May; 13(5):1051-1058. PubMed ID: 28068212 [TBL] [Abstract][Full Text] [Related]